文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

核因子E2相关因子2蛋白通过调控铁死亡介导脓毒症相关肝损伤

[Nuclear factor E2-related factor 2 protein mediates sepsis-associated liver injury by regulating ferroptosis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2024-01-01
一句话结论小鼠CLP模型显示脓毒症相关肝损伤存在铁死亡,Nrf2蛋白通过调控铁死亡介导该损伤,抑制铁死亡或激活Nrf2可减轻肝损伤。

该研究将雄性SD小鼠随机分为6组(每组6只),以盲肠结扎穿孔(CLP)建立脓毒症相关肝损伤(SALI)模型,分别腹腔注射铁死亡抑制剂Fer-1 10 mg×kg-1×d-1、铁死亡激活剂Erastin 20 mg×kg-1×d-1、Nrf2抑制剂ML385 30 mg×kg-1×d-1、Nrf2激活剂姜黄素100 mg×kg-1×d-1,连续10天。结果CLP组出现肝损伤、线粒体缩短、MDA和Fe2+升高、GSH降低、Nrf2和GPX4表达下降、PTGS2表达升高;Fer-1和姜黄素组上述指标逆转,Erastin和ML385组则进一步恶化。作者认为CLP诱导的SALI可导致小鼠肝细胞铁死亡,肝组织Nrf2蛋白通过调控铁死亡介导SALI。

要点

  • CLP诱导SALI小鼠肝细胞发生铁死亡:肝组织MDA和Fe2+升高、GSH降低,线粒体长度缩短(1.07±0.25 μm)。
  • 铁死亡抑制剂Fer-1(10 mg×kg-1×d-1腹腔注射,连续10天)可降低CLP小鼠ALT(80.65±19.44 U/L)和AST(103.33±11.90 U/L),并升高线粒体长度(1.42±0.09 μm),均P<0.05。
  • Nrf2激活剂姜黄素(100 mg×kg-1×d-1腹腔注射,连续10天)同样降低ALT(103.45±20.52 U/L)和AST(127.33±15.79 U/L),升高线粒体长度(1.43±0.21 μm),均P<0.05。
  • 铁死亡激活剂Erastin(20 mg×kg-1×d-1)和Nrf2抑制剂ML385(30 mg×kg-1×d-1)使CLP小鼠肝损伤加重,ALT分别升至344.52±40.79 U/L和321.70±21.10 U/L,均P<0.05。
  • CLP组肝组织Nrf2和GPX4蛋白表达下降、PTGS2表达升高;Fer-1和姜黄素组Nrf2、GPX4升高、PTGS2降低,Erastin和ML385组相反,均P<0.05。

适用人群与场景

  • 雄性Sprague-Dawley(SD)小鼠,采用盲肠结扎穿孔(CLP)建立脓毒症相关肝损伤(SALI)模型;Sham组仅行开腹术。

处置流程与药物剂量

  • CLP+Fer-1组:CLP后腹腔注射铁死亡抑制剂Ferrostatin-1(Fer-1)10 mg×kg-1×d-1,连续10天。
  • CLP+Erastin组:CLP后腹腔注射铁死亡激活剂Erastin 20 mg×kg-1×d-1,连续10天。
  • CLP+ML385组:CLP后腹腔注射Nrf2抑制剂ML385 30 mg×kg-1×d-1,连续10天。
  • CLP+姜黄素组:CLP后腹腔注射Nrf2激活剂姜黄素100 mg×kg-1×d-1,连续10天。
  • Sham组和CLP组:给予生理盐水10 mg×kg-1×d-1,连续10天。

研究设计与关键结果

  • 研究类型:动物实验;雄性SD小鼠随机分为6组,每组6只,分别为Sham组、CLP组、CLP+Fer-1组、CLP+Erastin组、CLP+ML385组、CLP+姜黄素组。
  • 与Sham组比较,CLP组血清ALT和AST显著升高,肝索排列紊乱、细胞肿胀坏死、线粒体长度显著缩短,肝组织MDA和Fe2+水平显著升高、GSH含量显著降低,肝组织Nrf2和GPX4蛋白表达降低、PTGS2蛋白表达显著升高。
  • 与CLP组比较,CLP+Fer-1组和CLP+姜黄素组血清ALT和AST显著降低[ALT(U/L):80.65±19.44、103.45±20.52 vs. 283.50±37.12,AST(U/L):103.33±11.90、127.33±15.79 vs. 288.67±36.82,均P<0.05];镜下肝索排列不规则、细胞轻度肿胀,线粒体长度显著增加(μm:1.42±0.09、1.43±0.21 vs. 1.07±0.25,均P<0.05);
  • 与CLP组比较,CLP+Erastin组和CLP+ML385组上述指标结果相反,血清ALT和AST显著升高[ALT(U/L):344.52±40.79、321.70±21.10 vs. 283.50±37.12,AST(U/L):333.50±27.90、333.00±16.67 vs. 288.67±36.82,均P<0.05];镜下肝索排列紊乱、细胞明显肿胀坏死,线粒体长度显著缩短(μm:0.78±0.13、0.67±0.07 vs. 1.07±0.25,均P<0.05);

证据类型、等级与局限

  • 证据类型:动物实验(小鼠CLP模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为CLP诱导的SALI可导致小鼠肝细胞铁死亡,肝组织Nrf2蛋白通过调控铁死亡介导SALI。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the effect of nuclear factor E2-related factor 2 (Nrf2) protein on ferroptosis in mice with sepsis-associated liver injury (SALI).

METHODS: he male Sprague-Dawley (SD) mice were divided into 6 groups according to the random number table method, with 6 mice in each group. The SALI model of mice was established by cecal ligation and puncture (CLP), and the Sham group was only treated with laparotomy. CLP+Fer-1 group, CLP+Erastin group, CLP+ML385 group and CLP+Curcumin group were intraperitoneally injected with iron death inhibitor Ferrostatin-1 (Fer-1) 10 mg×kg-1×d-1, iron death activator Erastin 20 mg×kg-1×d-1, Nrf2 inhibitor ML385 30 mg×kg-1×d-1 and Nrf2 activator Curcumin 100 mg×kg-1×d-1 after CLP, respectively; Sham group and CLP group were given normal saline 10 mg×kg-1×d-1, each group was administered continuously for 10 days. Ten days after operation, the serum and liver tissues of mice were collected to detect the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum, and the levels of malondialdehyde (MDA), glutathione (GSH) and Fe2+; in liver homogenate. The pathological changes of liver tissue were observed under light microscope after hematoxylin-eosin (HE) staining. The shape and length of mitochondria in liver cells were observed under transmission electron microscope. The protein expressions of Nrf2, glutathione peroxidase 4 (GPX4) and prostaglandin-endoperoxide synthase 2 (PTGS2) in liver tissue were detected by Western blotting.

RESULTS: Compared with Sham group, the serum levels of ALT and AST in the CLP group were significantly increased; histologically, the hepatic cord was disordered, the cells were swollen and necrotic, and the length of mitochondria was significantly shortened; the levels of MDA and Fe2+ in liver tissue increased significantly, and the content of GSH decreased significantly; the protein expressions of Nrf2 and GPX4 in liver tissue decreased, and the protein expression of PTGS2 increased significantly. Compared with CLP group, the serum levels of ALT and AST in CLP+Fer-1 group and CLP+Curcumin group were significantly decreased [ALT (U/L): 80.65±19.44, 103.45±20.52 vs. 283.50±37.12, AST (U/L): 103.33±11.90, 127.33±15.79 vs. 288.67±36.82, all P < 0.05]; microscopically, the hepatic cord was irregular, the cells were slightly swollen, and the mitochondrial length was significantly increased (μm: 1.42±0.09, 1.43±0.21 vs. 1.07±0.25, both P < 0.05); the levels of MDA and Fe2+; in liver tissue decreased significantly, and the content of GSH increased significantly [MDA (mol/g): 0.87±0.23, 1.85±0.43 vs. 4.47±0.95, Fe2+ (μg/g): 63.80±7.15, 67.48±6.28 vs. 134.52±14.32, GSH (mol/g): 1.95±0.29, 1.95±0.45 vs. 0.55±0.29, all P < 0.05]; the protein expressions of Nrf2 and GPX4 in liver tissue were significantly increased, and the protein expression of PTGS2 was significantly decreased (Nrf2/GAPDH: 1.80±0.28, 2.10±0.43 vs. 0.70±0.24, GPX4/GAPDH: 0.80±0.06, 0.93±0.07 vs. 0.48±0.02, PTGS2/GAPDH: 0.76±0.05, 0.84±0.01 vs. 1.02±0.09, all P < 0.05). However, the results of the above indexes in the CLP+Erastin group and CLP+ML385 group were opposite, and the serum levels of ALT and AST were significantly increased [ALT (U/L): 344.52±40.79, 321.70±21.10 vs. 283.50±37.12, AST (U/L): 333.50±27.90, 333.00±16.67 vs. 288.67±36.82, all P < 0.05]; microscopically, the arrangement of hepatic cords was disordered, the cells were obviously swollen and necrotic, and the length of mitochondria was significantly shortened (μm: 0.78±0.13, 0.67±0.07 vs. 1.07±0.25, both P < 0.05); the levels of MDA and Fe2+ in liver tissue increased significantly, and the content of GSH decreased significantly [MDA (mol/g): 5.92±1.06, 5.62±0.56 vs. 4.47±0.95, Fe2+ (μg/g): 151.40±8.03, 151.88±8.68 vs. 134.52±14.32, GSH (mol/g): 0.25±0.08, 0.23±0.11 vs. 0.55±0.29, all P < 0.05]; the protein expressions of Nrf2 and GPX4 in liver tissue were significantly decreased, and the protein expression of PTGS2 was significantly increased (Nrf2/GAPDH: 0.46±0.09, 0.46±0.11 vs. 0.70±0.24, GPX4/GAPDH: 0.34±0.05, 0.40±0.01 vs. 0.48±0.02, PTGS2/GAPDH: 1.24±0.13, 1.16±0.11 vs. 1.02±0.09, all P < 0.05).

CONCLUSIONS: CLP-induced SALI can lead to ferroptosis in mice hepatocytes, and Nrf2 protein in liver tissue can mediate SALI by regulating ferroptosis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhong Z, Ouyang X, Guo Q, et al. [Nuclear factor E2-related factor 2 protein mediates sepsis-associated liver injury by regulating ferroptosis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38845495. doi:10.3760/cma.j.cn121430-20231105-00941

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。